← Back to Search

MyPath Decision Support Tool for Reproductive Health (MyPath Trial)

N/A
Recruiting
Led By Lisa S Callegari, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients: Female sex identified in medical record
Patients: 18 - 44 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

MyPath Trial Summary

This trial will test a web-based decision tool to help women Veterans get information and care related to their reproductive goals. The goal is to see if this will empower them to have more successful pregnancies or avoid unwanted pregnancies.

Who is the study for?
This trial is for women Veterans aged 18-44 who want information or to discuss pregnancy and birth control with their provider. They must have a scheduled VA appointment, be proficient in English, and not currently pregnant or without reproductive organs due to surgery.Check my eligibility
What is being tested?
The study tests a web-based tool designed to support reproductive decisions. Participants are randomly divided: one group receives a weblink to the tool before their VA appointment; the other does not. The goal is better patient-provider communication and informed choices.See study design
What are the potential side effects?
Since this intervention involves informational and decision support rather than medication or medical procedures, there are no direct physical side effects expected from using the MyPath Web-Based Tool.

MyPath Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My medical records identify me as female.
Select...
I am between 18 and 44 years old.

MyPath Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Occurrence of reproductive needs discussion with shared decision making (SDM).
Secondary outcome measures
Choice of prescription or procedural contraceptive method.
Choice of procedural contraceptive method.
Confidence that chosen contraceptive method is "right for me."
+13 more
Other outcome measures
Behaviors to modify prepregnancy health risks
Goals-concordant consistent contraceptive use.
Goals-concordant continuous contraceptive use.
+3 more

MyPath Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (MyPath)Experimental Treatment1 Intervention
Patients scheduled to see providers randomized to this arm will receive a weblink to the decision tool via text message after study enrollment and prior to their scheduled visit.
Group II: Usual CareActive Control1 Intervention
Patients scheduled to see providers randomized to the usual care arm will receive no intervention and will receive usual primary care.

Find a Location

Who is running the clinical trial?

Kaiser PermanenteOTHER
538 Previous Clinical Trials
24,112,637 Total Patients Enrolled
University of California, San FranciscoOTHER
2,506 Previous Clinical Trials
15,238,099 Total Patients Enrolled
5 Trials studying Reproductive Health
6,874 Patients Enrolled for Reproductive Health
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,828 Total Patients Enrolled

Media Library

MyPath Web-Based Informational and Decision Support Tool Clinical Trial Eligibility Overview. Trial Name: NCT04584294 — N/A
MyPath Web-Based Informational and Decision Support Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT04584294 — N/A
Reproductive Health Research Study Groups: Usual Care, Intervention (MyPath)
Reproductive Health Clinical Trial 2023: MyPath Web-Based Informational and Decision Support Tool Highlights & Side Effects. Trial Name: NCT04584294 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being sought for this trial?

"Affirmative. According to information on clinicaltrials.gov, this experiment is currently in search of participants and was initially uploaded on March 1st 2021. As of October 18th 2022, 456 patients need to be recruited from 9 separate trial sites."

Answered by AI

Are geriatric patients welcome to join this medical study?

"This research is only open to individuals aged 18 and over, but under 44 years of age."

Answered by AI

What is the participant quota for this clinical exploration?

"Affirmative. According to clinicaltrials.gov, this trial opened for registration on March 1st 2021 and is currently ongoing; an update was last made on October 18th 2022. Nine different medical sites are actively recruiting a total of 456 participants."

Answered by AI

Are there a plethora of sites across the United States conducting this research?

"Nine locations are currently recruiting patients for this trial, including the Orlando VA Medical Center (Orlando, FL), the Seattle Division of the VA Puget Sound Health Care System (Seattle, WA) and Durham VA Medical Center (Durham, NC). Additionally, there are 6 additional clinical sites participating in recruitment."

Answered by AI

What are the eligibility requirements for participants in this clinical research?

"For eligibility in this clinical trial, interested individuals must have reproductive health and be between 18-44 years old. 456 subjects are slated to take part in the research."

Answered by AI
~44 spots leftby Aug 2024